Amphastar Pharmaceuticals (AMPH) Short Interest Ratio & Short Volume $44.30 -0.62 (-1.38%) (As of 12/4/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Amphastar Pharmaceuticals Short Interest DataAmphastar Pharmaceuticals (AMPH) has a short interest of 4.24 million shares, representing 11.80% of the float (the number of shares available for trading by the public). This marks a -2.30% decrease in short interest from the previous month. The short interest ratio (days to cover) is 12.0, indicating that it would take 12.0 days of the average trading volume of 398,480 shares to cover all short positions.Current Short Interest4,240,000 sharesPrevious Short Interest4,340,000 sharesChange Vs. Previous Month-2.30%Dollar Volume Sold Short$189.15 millionShort Interest Ratio12.0 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares48,081,000 sharesFloat Size35,940,000 sharesShort Percent of Float11.80%Today's Trading Volume401,343 sharesAverage Trading Volume398,480 sharesToday's Volume Vs. Average101% Short Selling Amphastar Pharmaceuticals? Sign up to receive the latest short interest report for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAMPH Short Interest Over TimeAMPH Days to Cover Over TimeAMPH Percentage of Float Shorted Over Time Ad Behind the MarketsWhy Trump's Win Can't Stop the Coming Crisis - Protect Yourself Now We are soon facing one of the biggest transfers of wealth this country has ever seen. If you're not ready for what's coming, you risk losing everything. Everything you need to know - and how to protect yourself - is in my new emergency briefing.Watch my emergency briefing here >>> Amphastar Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20244,240,000 shares $189.15 million -2.3%11.8%12 $44.61 10/31/20244,340,000 shares $219.30 million +2.6%12.2%12.6 $50.53 10/15/20244,230,000 shares $208.58 million -2.8%11.7%12 $49.31 9/30/20244,350,000 shares $211.11 million +5.3%12.0%11.9 $48.53 9/15/20244,130,000 shares $198.61 million -1.9%11.4%10.4 $48.09 8/31/20244,210,000 shares $205.20 million No Change12.0%11.2 $48.74 Get the Latest News and Ratings for AMPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/15/20244,210,000 shares $190.80 million -7.5%12.0%10.9 $45.32 7/31/20244,550,000 shares $198.02 million +7.6%12.9%11.6 $43.52 7/15/20244,230,000 shares $163.95 million +1.4%12.0%11.7 $38.76 6/30/20244,170,000 shares $166.80 million +0.5%11.9%11.5 $40.00 6/15/20244,150,000 shares $168.03 million +10.4%11.8%12.1 $40.49 5/31/20243,760,000 shares $159.16 million -0.3%10.3%10.3 $42.33 5/15/20243,770,000 shares $160.00 million -5.5%10.7%9.2 $42.44 4/30/20243,990,000 shares $164.59 million +3.1%11.4%9.7 $41.25 4/15/20243,870,000 shares $157.82 million +5.5%11.0%9 $40.78 3/31/20243,670,000 shares $161.15 million +1.9%10.6%7.8 $43.91 3/15/20243,600,000 shares $154.98 million -3.2%10.4%7.5 $43.05 2/29/20243,720,000 shares $173.24 million +3.6%10.3%7.5 $46.57 2/15/20243,590,000 shares $199.28 million +12.5%10.0%7.9 $55.51 1/31/20243,190,000 shares $170.22 million +8.5%8.9%6.6 $53.36 1/15/20242,940,000 shares $159.38 million +5.8%8.2%6.5 $54.21 12/31/20232,780,000 shares $171.94 million -1.8%7.8%6.5 $61.85 12/15/20232,830,000 shares $160.18 million -0.7%8.0%6.9 $56.60 11/30/20232,850,000 shares $160.51 million -1.4%8.0%6 $56.32 11/15/20232,890,000 shares $166.23 million +15.6%8.1%6.4 $57.52 10/31/20232,500,000 shares $113.18 million -6.0%6.9%5.7 $45.27 10/15/20232,660,000 shares $121.72 million +1.5%7.3%6.2 $45.76 9/30/20232,620,000 shares $120.49 million -2.6%7.2%5.8 $45.99 9/15/20232,690,000 shares $123.12 million +106.9%7.4%5.9 $45.77 8/31/20231,300,000 shares $69.30 million -12.8%3.6%3 $53.31 8/15/20231,490,000 shares $85.30 million +4.2%4.1%3.4 $57.25 7/31/20231,430,000 shares $86.79 million -30.9%4.0%3.2 $60.69 7/15/20232,070,000 shares $115.65 million +3.0%5.8%4.5 $55.87 6/30/20232,010,000 shares $115.51 million -3.4%5.6%4.5 $57.47 6/15/20232,080,000 shares $108.64 million +10.6%5.8%4.7 $52.23 5/31/20231,880,000 shares $83.42 million -1.1%5.3%4.7 $44.37 5/15/20231,900,000 shares $79.34 million +2.2%5.3%4.8 $41.76 4/30/20231,860,000 shares $66.53 million +29.2%5.3%5.3 $35.77 4/15/20231,440,000 shares $60.70 million +9.9%4.1%4.5 $42.15 3/31/20231,310,000 shares $49.13 million -10.3%3.7%4.6 $37.50Media Is Mocking Elon, But Wait Until They See This Demo (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/15/20231,460,000 shares $53.79 million -16.6%4.1%5.7 $36.84 2/28/20231,750,000 shares $55.76 million +1.2%4.7%7.4 $31.86 2/15/20231,730,000 shares $56.33 million +0.6%4.6%8.3 $32.56 1/31/20231,720,000 shares $52.05 million +1.2%4.6%8.1 $30.26 1/15/20231,700,000 shares $49.23 million -1.2%4.6%7.9 $28.96 12/30/20221,720,000 shares $48.19 million -2.3%4.6%7.9 $28.02 12/15/20221,760,000 shares $50.65 million -0.6%4.8%7.9 $28.78 11/30/20221,770,000 shares $52.20 million -3.8%4.8%7.7 $29.49 11/15/20221,840,000 shares $52.20 million -5.2%5.0%7.5 $28.37 10/31/20221,940,000 shares $59.95 million +1.6%5.2%6.9 $30.90 10/15/20221,910,000 shares $54.49 million +1.1%5.1%6.6 $28.53 9/30/20221,890,000 shares $53.11 million -9.1%5.0%6.2 $28.10 9/15/20222,080,000 shares $61.01 million -5.0%5.6%6 $29.33 8/31/20222,190,000 shares $64.82 million +1.4%5.9%5.1 $29.60 8/15/20222,160,000 shares $70.26 million -5.7%5.8%4.2 $32.53 7/31/20222,290,000 shares $85.62 million -3.0%6.1%4.1 $37.39 7/15/20222,360,000 shares $87.41 million +2.6%6.3%4.2 $37.04 6/30/20222,300,000 shares $80.02 million -11.5%6.2%3.8 $34.79 6/15/20222,600,000 shares $81.43 million +11.1%7.0%4.3 $31.32 5/31/20222,340,000 shares $86.91 million -6.8%6.3%4.3 $37.14 5/15/20222,510,000 shares $88.70 million +6.8%6.8%5.1 $35.34 4/30/20222,350,000 shares $83.35 million +15.2%6.4%5 $35.47 4/15/20222,040,000 shares $84.74 million +4.6%5.5%4.4 $41.54 3/31/20221,950,000 shares $70.01 million -3.5%5.4%4.7 $35.90 3/15/20222,020,000 shares $70.17 million +1.5%5.5%5.5 $34.74 2/28/20221,990,000 shares $55.14 million -2.9%5.5%6.3 $27.71 2/15/20222,050,000 shares $54.12 million +5.7%5.6%7.2 $26.40 1/31/20221,940,000 shares $44.79 million -1.5%5.6%7.1 $23.09 1/15/20221,970,000 shares $49.98 million -2.0%5.7%9.2 $25.37 12/31/20212,010,000 shares $46.81 million -2.9%5.8%10 $23.29 12/15/20212,070,000 shares $46.26 million -2.4%6.0%11.3 $22.35 11/30/20212,120,000 shares $41.47 million +7.1%6.1%12.5 $19.56 11/15/20211,980,000 shares $41.88 million -14.3%5.7%11.9 $21.15 10/29/20212,310,000 shares $43.15 million +1.3%6.6%16.3 $18.68 10/15/20212,280,000 shares $43.57 million No Change6.5%15.2 $19.11 9/30/20212,280,000 shares $43.34 million -5.8%6.5%14.1 $19.01 9/15/20212,420,000 shares $43.27 million +0.8%6.9%12.5 $17.88 8/31/20212,400,000 shares $47.09 million +3.0%6.9%11 $19.62 8/13/20212,330,000 shares $45.67 million -2.5%6.7%10.5 $19.60 7/30/20212,390,000 shares $50.07 million -1.2%6.9%10.2 $20.95 7/15/20212,420,000 shares $48.45 million -0.8%7.0%11 $20.02 6/30/20212,440,000 shares $49.19 million -7.9%7.1%11.1 $20.16 6/15/20212,650,000 shares $52.95 million +1.9%7.7%14.4 $19.98 5/28/20212,600,000 shares $49.19 million No Change7.5%15.4 $18.92 5/14/20212,600,000 shares $50.86 million -1.1%7.5%13.4 $19.56 4/30/20212,630,000 shares $46.21 million +3.5%7.6%13.7 $17.57 4/15/20212,540,000 shares $44.20 million +2.8%7.3%13.5 $17.40 3/31/20212,470,000 shares $44.46 million +2.9%7.3%12.6 $18.00 3/15/20212,400,000 shares $46.46 million -6.6%7.1%11.2 $19.36 2/26/20212,570,000 shares $45.98 million +0.8%7.5%12 $17.89Media Is Mocking Elon, But Wait Until They See This Demo (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 2/12/20212,550,000 shares $48.81 million -1.9%7.5%13.1 $19.14 1/29/20212,600,000 shares $48.28 million +1.6%7.3%12.8 $18.57 1/15/20212,560,000 shares $49.31 million -4.1%7.1%12.6 $19.26 12/31/20202,670,000 shares $53.00 million +3.5%7.5%13.6 $19.85 12/15/20202,580,000 shares $48.63 million -3.4%7.2%13.5 $18.85 11/30/20202,670,000 shares $48.38 million -0.7%7.5%13.8 $18.12 11/15/20202,690,000 shares $52.11 million No Change7.5%14.3 $19.37 10/30/20202,690,000 shares $54.04 million -2.2%7.5%15.1 $20.09 10/15/20202,750,000 shares $57.37 million +2.6%7.7%14.1 $20.86 9/30/20202,680,000 shares $50.25 million +7.2%7.5%12.2 $18.75 9/15/20202,500,000 shares $48.75 million -1.2%7.0%10.6 $19.50 8/31/20202,530,000 shares $51.56 million +0.8%7.1%9.9 $20.38 8/14/20202,510,000 shares $51.05 million -6.3%7.1%8.6 $20.34 7/31/20202,680,000 shares $53.65 million +1.9%7.8%7.8 $20.02 7/15/20202,630,000 shares $53.31 million -6.7%7.6%7.6 $20.27 6/30/20202,820,000 shares $62.38 million -8.1%8.2%8.2 $22.12 6/15/20203,070,000 shares $61.22 million -4.1%8.9%9.1 $19.94 5/29/20203,200,000 shares $59.65 million No Change9.2%9.4 $18.64 5/15/20203,200,000 shares $58.18 million -1.2%9.3%9.7 $18.18 4/30/20203,240,000 shares $54.92 million +8.4%9.3%12 $16.95 4/15/20202,990,000 shares $49.10 million +3.5%8.6%11.6 $16.42 3/31/20202,890,000 shares $48.35 million -1.9%8.3%11.4 $16.73 3/13/20202,944,500 shares $48.53 million +4.4%8.7%9.4 $16.48 2/28/20202,820,000 shares $37.20 million +4.8%8.3%12.8 $13.19 2/14/20202,690,000 shares $41.40 million -1.1%7.5%12.5 $15.39 1/31/20202,720,000 shares $47.00 million No Change7.7%12 $17.28 1/15/20202,720,000 shares $54.32 million +0.7%7.7%11.7 $19.97 12/31/20192,700,000 shares $53.03 million -5.6%7.6%11.9 $19.64 AMPH Short Interest - Frequently Asked Questions What is Amphastar Pharmaceuticals' current short interest? Short interest is the volume of Amphastar Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 15th, investors have sold 4,240,000 shares of AMPH short. 11.80% of Amphastar Pharmaceuticals' shares are currently sold short. Learn More on Amphastar Pharmaceuticals' current short interest. What is a good short interest ratio for Amphastar Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMPH shares currently have a short interest ratio of 12.0. Learn More on Amphastar Pharmaceuticals's short interest ratio. Which institutional investors are shorting Amphastar Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amphastar Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Amphastar Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.80% of Amphastar Pharmaceuticals' floating shares are currently sold short. Is Amphastar Pharmaceuticals' short interest increasing or decreasing? Amphastar Pharmaceuticals saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 4,240,000 shares, a decline of 2.3% from the previous total of 4,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amphastar Pharmaceuticals' float size? Amphastar Pharmaceuticals currently has issued a total of 48,081,000 shares. Some of Amphastar Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amphastar Pharmaceuticals currently has a public float of 35,940,000 shares. How does Amphastar Pharmaceuticals' short interest compare to its competitors? 11.80% of Amphastar Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Amphastar Pharmaceuticals: Ascendis Pharma A/S (5.89%), Legend Biotech Co. (12.49%), Nuvalent, Inc. (11.82%), Elanco Animal Health Incorporated (3.07%), Lantheus Holdings, Inc. (6.40%), Blueprint Medicines Co. (6.15%), Cytokinetics, Incorporated (12.84%), Viking Therapeutics, Inc. (15.25%), Krystal Biotech, Inc. (12.52%), TG Therapeutics, Inc. (20.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short Amphastar Pharmaceuticals stock? Short selling AMPH is an investing strategy that aims to generate trading profit from Amphastar Pharmaceuticals as its price is falling. AMPH shares are trading down $0.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amphastar Pharmaceuticals? A short squeeze for Amphastar Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMPH, which in turn drives the price of the stock up even further. How often is Amphastar Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMPH, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies Ascendis Pharma A/S Short Squeeze Legend Biotech Short Squeeze Nuvalent Short Squeeze Elanco Animal Health Short Squeeze Lantheus Short Squeeze Blueprint Medicines Short Squeeze Cytokinetics Short Squeeze Viking Therapeutics Short Squeeze Krystal Biotech Short Squeeze TG Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMPH) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThis frightening chart explains everything going on in the economy (see photo)Why the wealth gap is getting wider — with the one percenters growing ever richer and ever more powerful, whil...Banyan Hill Publishing | SponsoredExpert: The most important message you’ll see in 2024The message I'm sharing today could be the most important message of 2024. In short, America is being invad...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMPH Stock Alerts